bupropioni hydrochloridum 300 mg, povidonum K 90, cysteini hydrochloridum monohydricum, silica colloidalis anhydrica, glyceroli dibehenas, magnesii stearas, Überzug: ethylcellulosum, povidonum K 90, macrogolum 1450, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.005 mg, polysorbatum 80, silica colloidalis hydrica, triethylis citras, Drucktinte: lacca, E 172 (nigrum), alcohol butylicus, propylenglycolum, ammoniae solutio 28 per centum, pro compresso obducto.
Packungsbestandteile
Delayed release tablets
Active Agent
Dose
Bupropion Hydrochloride
300 mg
BAG: Active Agent
Dose
Bupropion Hydrochloride
300 mg
Inactive agents
Dose
additional_information
(Nigrum)
Acidi Methacrylici
Alcohol Butylicus
Ammoniae Solutio
28
Cystein Hydrochloride Monohydrate
E 172
color.
Ethylcellulosum
Überzug
Ethylis Acrylatis Polymerisatum
Glyceroli Dibehenas
Lacca
Drucktinte
Macrogol
1450
Magnesii Stearas
Natrii Laurilsulfas
Per Centum
Polysorbatum 80
Povidonum K
90
Pro Compresso Obducto
Propylenglycol
Silica Colloidalis Anhydrica
Silica Colloidalis Hydrica
Triethylis Citras
Source
Data was imported : 05.01.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
